請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44493完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳俊任(Chun-Jen Chen) | |
| dc.contributor.author | Chia-Chen Pi | en |
| dc.contributor.author | 畢家甄 | zh_TW |
| dc.date.accessioned | 2021-06-15T03:00:58Z | - |
| dc.date.available | 2014-08-06 | |
| dc.date.copyright | 2009-08-06 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-31 | |
| dc.identifier.citation | 1. Paterson, R. R. 2006. Ganoderma - a therapeutic fungal biofactory. Phytochemistry 67:1985-2001.
2. Lin, J. M., C. C. Lin, M. F. Chen, T. Ujiie, and A. Takada. 1995. Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J Ethnopharmacol 47:33-41. 3. Ukai, S., T. Kiho, C. Hara, I. Kuruma, and Y. Tanaka. 1983. Polysaccharides in fungi. XIV. Anti-inflammatory effect of the polysaccharides from the fruit bodies of several fungi. J Pharmacobiodyn 6:983-990. 4. Sliva, D. 2006. Ganoderma lucidum in cancer research. Leuk Res 30:767-768. 5. Yoon, S. Y., S. K. Eo, Y. S. Kim, C. K. Lee, and S. S. Han. 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res 17:438-442. 6. Shiao, M. S. 1992. Triterpenoid natural products in the fungus Ganoderma lucidum. J. Chin. Chem. Soc. 39:669–674. 7. Lin, S. B., C. H. Li, S. S. Lee, and L. S. Kan. 2003. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72:2381-2390. 8. Zhu, M., Q. Chang, L. K. Wong, F. S. Chong, and R. C. Li. 1999. Triterpene antioxidants from ganoderma lucidum. Phytother Res 13:529-531. 9. Kim, D. H., S. B. Shim, N. J. Kim, and I. S. Jang. 1999. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 22:162-164. 10. Hajjaj, H., C. Mace, M. Roberts, P. Niederberger, and L. B. Fay. 2005. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Appl Environ Microbiol 71:3653-3658. 11. Morigiwa, A., K. Kitabatake, Y. Fujimoto, and N. Ikekawa. 1986. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull (Tokyo) 34:3025-3028. 12. Gan, K. H., Y. F. Fann, S. H. Hsu, K. W. Kuo, and C. N. Lin. 1998. Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J Nat Prod 61:485-487. 13. Zhao, H. B., S. Z. Wang, Q. H. He, L. Yuan, A. F. Chen, and Z. B. Lin. 2005. Ganoderma total sterol (GS) and GS1 protect rat cerebral cortical neurons from hypoxia/reoxygenation injury. Life Sci 76:1027-1037. 14. Kleinwachter, P., N. Anh, T. T. Kiet, B. Schlegel, H. M. Dahse, A. Hartl, and U. Grafe. 2001. Colossolactones, new triterpenoid metabolites from a Vietnamese mushroom Ganoderma colossum. J Nat Prod 64:236-239. 15. Mothana, R. A., R. Jansen, W. D. Julich, and U. Lindequist. 2000. Ganomycins A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod 63:416-418. 16. Wang, G., J. Zhang, T. Mizuno, C. Zhuang, H. Ito, H. Mayuzumi, H. Okamoto, and J. Li. 1993. Antitumor active polysaccharides from the Chinese mushroom Songshan lingzhi, the fruiting body of Ganoderma tsugae. Biosci Biotechnol Biochem 57:894-900. 17. Wasser, S. P. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60:258-274. 18. Li, Y. B., R. Wang, H. L. Wu, Y. H. Li, L. J. Zhong, H. M. Yu, and X. J. Li. 2008. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells. Oncol Rep 20:549-556. 19. Lei, L. S., and Z. B. Lin. 1993. [Effects of Ganoderma polysaccharides on the activity of DNA polymerase alpha of splenocytes and immune function in aged mice]. Yao Xue Xue Bao 28:577-582. 20. Tanaka, S., K. Ko, K. Kino, K. Tsuchiya, A. Yamashita, A. Murasugi, S. Sakuma, and H. Tsunoo. 1989. Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidium, having similarity to immunoglobulin variable regions. J Biol Chem 264:16372-16377. 21. Lin, Y. L., Y. C. Liang, Y. S. Tseng, H. Y. Huang, S. Y. Chou, R. S. Hseu, C. T. Huang, and B. L. Chiang. 2009. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-{kappa}B and MAPK pathways. J Leukoc Biol. 22. Hart, D. N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245-3287. 23. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702. 24. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immunity. N Engl J Med 343:338-344. 25. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4:24-34. 26. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667. 27. Feili-Hariri, M., D. H. Falkner, and P. A. Morel. 2005. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J Leukoc Biol 78:656-664. 28. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-655. 29. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 185:817-824. 30. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132. 31. Cox, J. C., and A. R. Coulter. 1997. Adjuvants--a classification and review of their modes of action. Vaccine 15:248-256. 32. Billiau, A., and P. Matthys. 2001. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70:849-860. 33. Yip, H. C., A. Y. Karulin, M. Tary-Lehmann, M. D. Hesse, H. Radeke, P. S. Heeger, R. P. Trezza, F. P. Heinzel, T. Forsthuber, and P. V. Lehmann. 1999. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 162:3942-3949. 34. Lindblad, E. B. 2004. Aluminium compounds for use in vaccines. Immunol Cell Biol 82:497-505. 35. Bochner, B. S., B. J. Undem, and L. M. Lichtenstein. 1994. Immunological aspects of allergic asthma. Annu Rev Immunol 12:295-335. 36. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17:255-281. 37. van Rijt, L. S., and B. N. Lambrecht. 2005. Dendritic cells in asthma: a function beyond sensitization. Clin Exp Allergy 35:1125-1134. 38. Galli, S. J., M. Tsai, and A. M. Piliponsky. 2008. The development of allergic inflammation. Nature 454:445-454. 39. Kay, A. B. 2001. Allergy and allergic diseases. First of two parts. N Engl J Med 344:30-37. 40. Holgate, S. T. 1999. The epidemic of allergy and asthma. Nature 402:B2-4. 41. Tattersfield, A. E., A. J. Knox, J. R. Britton, and I. P. Hall. 2002. Asthma. Lancet 360:1313-1322. 42. Barnes, P. J. 2004. New drugs for asthma. Nat Rev Drug Discov 3:831-844. 43. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34-40. 44. Chu, C. L., and C. A. Lowell. 2005. The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation. J Immunol 175:2880-2889. 45. Lin, Y. L., S. S. Lee, S. M. Hou, and B. L. Chiang. 2006. Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice. Mol Pharmacol 70:637-644. 46. Lee, C. C., H. Y. Huang, and B. L. Chiang. 2008. Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 16:60-65. 47. Huang, H. Y., C. C. Lee, and B. L. Chiang. 2009. Short hairpin RNAs against eotaxin or interleukin-5 decrease airway eosinophilia and hyper-responsiveness in a murine model of asthma. J Gene Med 11:112-118. 48. Smith, J. E., Rowan, N.J., Sullivan, R. 2002. Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities. Biotechnol. Let 24:1839-1845. 49. Cao, L. Z., and Z. B. Lin. 2002. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett 83:163-169. 50. Quakyi, E. K., P. H. Carter, C. M. Tsai, and G. E. Marti. 1997. Immunization with meningococcal membrane-bound lipooligosaccharide accelerates granulocyte recovery and enhances lymphocyte proliferation in myelosuppressed mice. Pathobiology 65:26-38. 51. Wonderlich, J., G. Shearer, A. Livingstone, and A. Brooks. 2006. Induction and measurement of cytotoxic T lymphocyte activity. Curr Protoc Immunol Chapter 3:Unit 3 11. 52. Lack, G., K. L. Bradley, E. Hamelmann, H. Renz, J. Loader, D. Y. Leung, G. Larsen, and E. W. Gelfand. 1996. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol 157:1432-1439. 53. Barnes, P. J. 2001. IL-10: a key regulator of allergic disease. Clin Exp Allergy 31:667-669. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44493 | - |
| dc.description.abstract | 台灣紫芝是台灣特有的靈芝,在本篇研究中,我們從台灣紫芝的液態培養中分離出胞外多醣體(PS-F2),並利用PS-F2誘導小鼠骨髓細胞衍生之樹突細胞(BMDC)成熟並使之分泌細胞激素,結果顯示PS-F2可以增加成熟樹突細胞的表面分子CD40、CD80、CD86、MHC II的表現量,也可以增進成熟樹突細胞分泌TNF-α、IL-10、IL-12 p40和IL-6等細胞激素。此外,以PS-F2誘導的樹突細胞可以有效地呈現OVA323-339 peptide給OT II基因轉殖鼠的CD4+ T細胞,並刺激CD4+ T細胞產生細胞激素IFN-γ 和IL-17A。在動物實驗中,我們進一步的利用PS-F2作為免疫佐劑,以卵清蛋白 (OVA) 為抗原對小鼠進行免疫,發現PS-F2增加抗原專一性的免疫球蛋白,刺激Th1反應細胞激素IFN-γ生成,促進抗原專一性的脾臟細胞增生。在氣喘的動物模式中,以OVA作為抗原、氫氧化鋁作為佐劑與PS-F2混合均勻,腹腔注射至小鼠體內,結果顯示PS-F2可以有效的抑制Th2細胞激素所誘發的呼吸道發炎反應,減緩小鼠呼吸道過度反應,減少嗜酸性顆粒球滲入肺部,並降低血清中IgE的含量,在肺部沖洗液中可以明顯的發現Th1細胞激素IFN-γ增加,Th2細胞激素IL-4, IL-13, eotaxin下降。因此本篇研究指出台灣紫芝胞外多醣體PS-F2可以有效減緩過敏反應中的Th2細胞激素,改善過敏性氣喘的疾病。 | zh_TW |
| dc.description.abstract | Ganoderma formosanum is a unique Ganoderma species in Taiwan. In this study, we isolated the extracellular polysaccharide-fraction 2 (PS-F2) from the submerged culture of Ganoderma formosanum and demonstrated that PS-F2 induced the maturation and cytokine production in bone marrow-derived dendritic cells (BMDCs). Our results showed that PS-F2 stimulation enhanced the expression of BMDC maturation markers including CD40, CD80, CD86, and MHC II and the production of cytokines such as TNF-α, IL-10, IL-12p40, and IL-6. In addition, PS-F2-treated BMDCs presented the ovalbumin323-339 (OVA323-339) peptide to CD4+ T cells purified from OT II transgenic mice and stimulated T cells to produce IFN-γ and IL-17A. We further investigated whether PS-F2 could function as an adjuvant in vivo. We immunized mice with OVA antigen and found that PS-F2 could enhance anti-OVA immunoglobulin production and stimulate IFN-γ production. PS-F2 also induced OVA-specific splenocyte proliferation. In a murine asthmatic model, we evaluated whether PS-F2 could suppress Th2 cytokine-induced airway inflammation responses. BALB/c mice were immunized by intraperitoneally (i.p.) injection of OVA mixed with PS-F2 and aluminum hydroxide (Alum). PS-F2 administration attenuated airway hyper-responsiveness (AHR), reduced eosinophil infiltration and serum IgE levels. PS-F2 treatment also significantly enhanced IFN-γ production, increased IL-10 secretion, and reduced levels of Th2-type cytokines such as IL-4, IL-13, and eotaxin in the bronchoalveolar lavage fluid (BALF). Our results suggested that Ganoderma formosanum extracellular polysaccharide-fraction 2 might be beneficial for treating asthma disease through the suppression of Th2 response. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T03:00:58Z (GMT). No. of bitstreams: 1 ntu-98-R96b47101-1.pdf: 10416662 bytes, checksum: 143da2bf3469a4995b0d37325675f20e (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 中文摘要 ……………………………………………………………………..…...……I
Abstract ……………………………………………………………………………...…II Abbreviation ………………………………………………………………….……..…IV Contents …………………………………………………………………………….….VI Chapter I. Introduction 1. Ganoderma introduction ……….………………………………………………2 2. The role of Dendritic cell ………………………………………………………4 3. T cell differentiation …………………………………………………………....5 4. Characteristics of adjuvant ………………………………………………….….6 5. Characteristics of asthma ………………………………………………………7 6. Aims of the study ………………………………………………………………9 Chapter II. Materials and methods 1. Purification of PS-F2 from Ganoderma formosanum 1.1 Reagents …………………………………………………………………..….12 1.2 Fermentation of Ganoderma formosanum ………………………………...…12 1.3 Purification of polysaccharide-fraction 2 (PS-F2) …………………………...13 2. Analyses of immune responses stimulated by PS-F2 in vitro 2.1 Reagents ……………………………………………………………….……..14 2.2 Animals ……………………………………………………………………….14 2.3 Bone marrow-derived dendritic cell (BMDC) preparation and culture …...…15 2.4 Analysis for cytokine secretion by BMDCs …………………………….….. .15 2.5 Analysis for BMDC maturation…………………………………………....…16 2.6 Selection of CD4 T cells …………………………………………………..…16 2.7 Immune response analysis in vitro ………………………...…………………17 3. Study of PS-F2 function as an adjuvant 3.1 Immunization ……………………………………………………..………….18 3.2 OVA-specific antibody analysis ……………………………….……….…….19 3.3 Determination of cytokine levels ……………………………………….……19 3.4 Proliferation assay ………………………………………………….………...20 4. Immune modulation of PS-F2 in a murine asthmatic model 4.1 Mice senisitization, challenge and treatment …………………………………21 4.2 Measurement of airway hyper-responsiveness (AHR) ……………………….21 4.3 Bronchoalveolar lavage fluid (BALF) collection and analysis …………...….22 Chapter III. Results 1. Purification of PS-F2 from Ganoderma formosanum ………………………………25 2. Analyses of immune responses stimulated by PS-F2 in vitro 2.1 PS-F2 induced BMDC maturation …………………………………………...25 2.2 Cytokine secretion by PS-F2-treated BMDC ………………………………..26 2.3 PS-F2-treated BMDCs stimulated OT II CD4 T cells to produce Th1 and Th17 Cytokine ………………………………………………………………..26 3. Study of PS-F2 function as an adjuvant 3.1 OVA-specific antibody in serum ………………………………………….….27 3.2 Cytokine production from OVA-restimulated splenocytes ……………….….27 3.3 Splenocyte proliferation ………………………………………………….…..28 4. Immune modulation of PS-F2 in a murine asthmatic model 4.1 Serum OVA-specific antibody ………………………………………….……29 4.2 Airway hyper-responsiveness ………………………………………….…….29 4.3 Cytokine production in BALF ………………………………………….……30 4.4 Leukocytes population in BALF …………………………………….………30 Chapter IV. Discussion and conclusion Figures and tables………………37 References……………… 53 | |
| dc.language.iso | en | |
| dc.subject | 免疫佐劑 | zh_TW |
| dc.subject | OT-II基因轉殖鼠 | zh_TW |
| dc.subject | 干擾素-γ | zh_TW |
| dc.subject | 樹突細胞 | zh_TW |
| dc.subject | 台灣紫芝 | zh_TW |
| dc.subject | 呼吸道阻力 | zh_TW |
| dc.subject | 肺部沖洗液 | zh_TW |
| dc.subject | Ganoderma formosanum | en |
| dc.subject | dendritic cells | en |
| dc.subject | IFN-γ | en |
| dc.subject | OT II transgenic mice | en |
| dc.subject | adjuvant | en |
| dc.subject | asthma | en |
| dc.subject | airway hyper-responsiveness | en |
| dc.subject | bronchoalveolar lavage fluid | en |
| dc.title | 台灣紫芝胞外多醣體之免疫佐劑活性與調節小鼠氣喘反應之研究 | zh_TW |
| dc.title | Extracellular polysaccharides derived from Ganoderma formosanum function as an adjuvant and regulate allergic reaction in a murine asthmatic model | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 林璧鳳(Bi-Fong Lin),陳念榮(Nien-Jung Chen) | |
| dc.subject.keyword | 台灣紫芝,樹突細胞,干擾素-γ,OT-II基因轉殖鼠,免疫佐劑,呼吸道阻力,肺部沖洗液, | zh_TW |
| dc.subject.keyword | Ganoderma formosanum,dendritic cells,IFN-γ,OT II transgenic mice,adjuvant,asthma,airway hyper-responsiveness,bronchoalveolar lavage fluid, | en |
| dc.relation.page | 56 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-31 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 微生物與生化學研究所 | zh_TW |
| 顯示於系所單位: | 微生物學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 10.17 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
